Form 4: Idexx Laboratories Inc /De CFO Reports Stock Transaction
Insider Transaction (Form 4)
Andrew Emerson, EVP, CFO and Treasurer of Idexx Laboratories Inc /De, reported multiple transactions in common stock on August 20, 2026.
Summary
- Option exercise/conversion: acquired 265 Common Stock at $178.26 ($47,239) on August 20, 2026; holds 4,507 after (Direct).
- Tax/exercise-price withholding: disposed of 86 Common Stock on August 20, 2026; holds 4,421 after (Direct).
- Option exercise/conversion: disposed of 265 Incentive Stock Option (right-to-buy) on August 20, 2026; holds 925 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Emerson — Officer (EVP, CFO and Treasurer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Option exercise/conversion | Common Stock | 265 | $178 | $47.2K | 4,507.444 |
| 2026-08-20 | Tax/exercise-price withholding | Common Stock | 86 | — | — | 4,421.444 |
| 2026-08-20 | Option exercise/conversion | Incentive Stock Option (right-to-buy) | 265 | — | — | 925 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Option exercise/conversion (265 shares) |
| 2026-08-20 | Tax/exercise-price withholding (86 shares) |
| 2026-08-20 | Option exercise/conversion (265 shares) |
Keywords
insider transaction, Form 4, IDXX, IDEXX LABORATORIES INC /DE, neutral, Andrew Emerson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.